Skip to search formSkip to main contentSkip to account menu

KRN 633

Known as: KRN-633, KRN633 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
BACKGROUND Vascular endothelial growth factor (VEGF) is a master regulator and is required for the effective coupling of… 
2015
2015
Degeneration of retinal capillaries occurs following N‐methyl‐D‐aspartate (NMDA)‐induced retinal neurotoxicity, and the degree of… 
2014
2014
We have previously reported that treatment of newborn mice with KRN633, a vascular endothelial growth factor (VEGF) receptor… 
2013
2013
We previously reported that treatment with KRN633, a vascular endothelial growth factor receptor tyrosine kinase inhibitor… 
2011
2011
Angiogenesis plays an important role in bone development and postnatal bone fracture repair. Vascular endothelial growth factor… 
2011
2011
Purpose: To examine the role of both protein kinase C (PKC)-β and vascular endothelial growth factor receptor (VEGFR)-2 in… 
2011
2011
Objective To investigate the effects of Lovastatin combined with KRN633,a selective inhibitor of vascular endothelial growth… 
2010
2010
Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway during pregnancy contributes to several pathologic…